Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 315.50
Bid: 313.50
Ask: 315.50
Change: 0.00 (0.00%)
Spread: 2.00 (0.638%)
Open: 315.50
High: 315.50
Low: 315.00
Prev. Close: 315.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Morgan Crucible Co

16 Oct 2006 13:19

Schroders PLC16 October 2006 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) Schroders plcCompany dealt in Morgan Crucible Co PlcClass of relevant security to which the Ordinary 25pdealings being disclosed relate (Note 2)Date of dealing 13/10/06 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 32,492,453 11.074%(2) Derivatives (other than options) 267,345 0.091%(3) Options and agreements to purchase/sellTotal 32,492,453 11.074% 267,345 0.091% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and salesPurchase/sale Number of securities Price per unit (Note 5) Sale 31,354 274.996p (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5) CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name,e.g. Writing, Number of Exercise Type, e.g. Expiry Option moneypaidcall option selling, securities to which price American, date /received per purchasing, the option relates European etc. unit (Note 5) varying etc. (Note 7) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 16/10/06Contact name Andrea RoweTelephone number 020 7658 2521If a connected EFM, name of offeree/offeror with whichconnectedIf a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date purchased to which the option or (Note 2) American, e.g. call option derivative relates European etc. Call option Written 267,345 320.28p European 6/11/06 Ordinary shares Notes 1. Where there are open option positions or open derivative positions (exceptfor CFDs), full details should be given. Full details of any existingagreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and itsNotes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 202111:54 amRNSResult of AGM
6th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTrading Update
31st Mar 20212:08 pmRNSAnnual Financial Report
26th Mar 20219:54 amRNSHolding(s) in Company
24th Mar 202110:10 amRNSDirector/PDMR Shareholding
24th Mar 202110:08 amRNSDirector/PDMR Shareholding
24th Mar 202110:06 amRNSDirector/PDMR Shareholding
24th Mar 202110:05 amRNSDirector/PDMR Shareholding
4th Mar 202111:22 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSFinal Results
15th Dec 202012:34 pmRNSBlock listing Interim Review
6th Nov 20207:00 amRNSQ3 Trading Update
16th Oct 20202:11 pmRNSDirector/PDMR Shareholding
6th Oct 20201:40 pmRNSDirector/PDMR Shareholding
28th Sep 20209:33 amRNSDirector Declaration
28th Sep 20209:19 amRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSMorgan Advanced Materials announces divestment
10th Aug 202011:15 amRNSDirector/PDMR Shareholding
5th Aug 20205:16 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSHalf-Year Results
15th Jun 20204:09 pmRNSBlock listing Interim Review
15th Jun 20203:09 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSCOVID-19 update
20th May 20201:58 pmRNSDirector/PDMR Shareholding
7th May 20202:46 pmRNSResult of AGM
28th Apr 20209:15 amRNSDisclosure of Rights Attached to Listed Securities
9th Apr 20201:33 pmRNSNotice of AGM
2nd Apr 20205:01 pmRNSDirector/PDMR Shareholding
1st Apr 20201:04 pmRNSAnnual Financial Report
31st Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
19th Mar 202012:22 pmRNSDirector/PDMR Shareholding
12th Mar 202010:14 amRNSDirector/PDMR Shareholding
11th Mar 202010:57 amRNSDirector/PDMR Shareholding
3rd Mar 20205:29 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSFull-year Results
16th Dec 20199:10 amRNSBlock listing Interim Review
2nd Dec 20199:10 amRNSDirector Declaration
18th Nov 201911:00 amRNSDirector/PDMR Shareholding
13th Nov 20199:48 amRNSDirector/PDMR Shareholding
12th Nov 201912:23 pmRNSDirector/PDMR Shareholding
11th Nov 20194:04 pmRNSDirector/PDMR Shareholding
11th Nov 20192:44 pmRNSDirector/PDMR Shareholding
8th Nov 20197:00 amRNSTrading Update
23rd Oct 20191:56 pmRNSHolding(s) in Company
23rd Oct 20191:54 pmRNSHolding(s) in Company
23rd Sep 201912:03 pmRNSDirector/PDMR Shareholding
3rd Sep 20192:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.